Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-25-018043
Filing Date
2025-10-14
Accepted
2025-10-14 17:11:06
Documents
47
Period of Report
2025-08-31

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 569243
2 EX-31.1 ex31-1.htm EX-31.1 13092
3 EX-31.2 ex31-2.htm EX-31.2 13249
4 EX-32.1 ex32-1.htm EX-32.1 6610
5 EX-32.2 ex32-2.htm EX-32.2 6694
  Complete submission text file 0001493152-25-018043.txt   3794587

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE bmra-20250831.xsd EX-101.SCH 23605
7 XBRL CALCULATION FILE bmra-20250831_cal.xml EX-101.CAL 42892
8 XBRL DEFINITION FILE bmra-20250831_def.xml EX-101.DEF 107144
9 XBRL LABEL FILE bmra-20250831_lab.xml EX-101.LAB 254868
10 XBRL PRESENTATION FILE bmra-20250831_pre.xml EX-101.PRE 196027
49 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 503451
Mailing Address 17571 VON KARMAN AVENUE IRVINE CA 92614
Business Address 17571 VON KARMAN AVENUE IRVINE CA 92614 9493792875
BIOMERICA INC (Filer) CIK: 0000073290 (see all company filings)

EIN.: 952645573 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 001-37863 | Film No.: 251392577
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)